Tonghua Golden-Horse Pharmaceutical Industry Co,Ltd (SHE:000766)

Market Cap	17.97B
Revenue (ttm)	1.33B
Net Income (ttm)	58.83M
Shares Out	966.49M
EPS (ttm)	0.06
PE Ratio	297.08
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	42,991,312
Average Volume	25,461,671
Open	17.99
Previous Close	18.59
Day's Range	17.99 - 19.46
52-Week Range	12.66 - 19.85
Beta	0.21
RSI	59.65
Earnings Date	Apr 18, 2025

About SHE:000766

Tonghua Golden-Horse Pharmaceutical Industry Co,Ltd., together with its subsidiaries, engages in the research, development, manufacture, and sale of pharmaceutical products in China. Its products covers anti-tumor, microbial, cardiovascular, heat-clearing and detoxification, digestive system, skeletal muscle system, gynecological system, nervous system, and other fields. The company also provides bone peptides, protective chemical medicines, cardiovascular and cerebrovascular chinese patent medicines, heat-clearing and detoxifying medicines, an...

• Industry: Drug Manufacturers - Specialty & Generic
• Sector: Healthcare
• Founded: 1990
• Employees: 1,532
• Stock Exchange: Shenzhen Stock Exchange
• Ticker Symbol: 000766

Financial Performance

In 2024, SHE:000766's revenue was 1.32 billion, a decrease of -10.23% compared to the previous year's 1.47 billion. Earnings were 56.44 million, an increase of 28.46%.